skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaLogo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

78 Total results for product and free and sample content found

Medtech Insight

Start-Up Spotlight: Innovative Cardiovascular Solutions Hopes To Win Regulatory Nod For Embolic Protector For TAVR

By Bob Kronemyer 22 Mar 2019

Transcatheter aortic valve replacement (TAVR) is performed routinely using devices providing protection from stroke as standard of care. However, cerebral embolic protection devices currently available do not capture and remove emboli from all three vessels leading to the brain. The Emblok Embolic Protection System from Innovative Cardiovascular Solutions (ICS) has developed an embolic filter designed to protect all three cerebral vessels during TAVR and remove debris from the entire circulatory system.

Topic Medtech

View article

Meddevicetracker

Meddevicetracker's Real-time Device Market Data API Solution

19 Mar 2019

Bringing our trusted data to your systems – fast.

Topic Medtech

View infographic

Medtech Insight

Drug-Coating Safety Risk Acknowledged At Cardiology Gathering, But Cause Remains Elusive

By Elizabeth Orr 07 Mar 2019

Physicians and researchers in an all-day session at the Cardiovascular Research Technologies conference in Washington, DC, on March 5 largely backed the recent finding that paclitaxel-coated balloons and stents may be tied to a higher patient mortality rate. But the specific mechanism underlying the deaths remains unknown.

Topic Medtech

View article

Medtech Insight

4C Medical Plans First Early Feasibility Study For An Implantable In Japan

By Elizabeth Orr 07 Mar 2019

4C Medical plans to conduct both an early feasibility study and the pivotal trial for its mitral regurgitation treatment device simultaneously in Japan, the US and Canada. The company says the study is the first early feasibility study in Japan for an implantable device.

Topic Medtech

View article

Medtech Insight

GE Deals Biopharma Biz To Danaher For $21.4Bn; Planned Healthcare IPO Probably Won't Happen

By Catherine Longworth 27 Feb 2019

The proposed IPO for GE's healthcare business could be off the table, CEO Lawrence Culp said as GE announced plans to sell its biopharma business to Danaher for $21.4bn. The deal will provide the conglomerate with a much needed cash injection to handle its rising debts.

Topic BioPharmaceutical Medtech

View article

Medtech Insight

Medical Device Registration In UK Under A No Deal Brexit Questions Answered

By Amanda Maxwell 27 Feb 2019

The UK government is introducing new registration requirements for medical devices in the event of a no-deal Brexit. They will be rolled out according to the risk class of products. But some fundamental questions have arisen.

Topic Brexit Medtech

View article

Biomedtracker, Meddevicetracker

Biomedtracker: Early 2019 Outlook Report Extract

26 Feb 2019

In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.

Topic Drug approval Drug review Medtech

Single report

Medtech Insight

Spinal Implants Finding A Manageable Regulatory Pathway Through Complex EU MDR Wording

By Amanda Maxwell 22 Feb 2019

Efforts are underway by EU notified body groups to encourage a uniform interpretation of the EU MDR when it comes to the risk classification of spinal implants. Their work could also reduce the amount of unnecessary notified body and expert panel work on some implantable devices.

Topic Medtech

View article

Medtech Insight

Market Brief Bone Densitometer And Bone Turnover Markers Will Reach $3731M In 2023

By Marion Webb 22 Feb 2019

The global market for bone densitometers and bone turnover markers will reach $373.1m by 2023, driven in large part by the rising aging population and rising prevalence of osteoporosis.

Topic Medtech

View article
Show More

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
General enquiry

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now